2. Signaling Pathways
  3. Others
  4. Isotope-Labeled Compounds

Isotope-Labeled Compounds

Isotope-labeled compounds are chemical substances in which some atoms in their molecules are replaced by isotope atoms. The range of stable isotope products can cover from gases to complex molecules. Isotope-labeled compounds could provide a site-specific investigation of structures, making molecules easily detectable by mass spectrometry and NMR, and maintaining the physico-chemical properties of the target molecule at the same time. MCE isotope-labeled compounds are all stable isotope-labeled compounds and are non-radioactive labeled substances. MCE isotope-labeled compounds are unique tools for identifying and understanding biological and chemical processes. Stable isotope-labeled products are now getting more and more popular among scientists. The scope of application is gradually penetrating into various scientific fields, such as life sciences, food and medicine, agriculture, environment, geology, etc. Stable isotope-labeled compounds have a wide range of applications in the Life Science areas, such as Metabolomics, Proteomics, Clinical studies, Deuterium drugs, etc.

Isotope-Labeled Compounds Related Products (10876):

Cat. No. Product Name Effect Purity Chemical Structure
  • HY-15025S3
    Sildenafil-d5
    Sildenafil-d5 (UK-92480-d5) is deuterium labeled Sildenafil. Sildenafil (UK-92480) is a potent phosphodiesterase type 5 (PDE5) inhibitor with an IC50 of 5.22 nM.
    Sildenafil-d<sub>5</sub>
  • HY-132370S
    5-Hydroxy dantrolene-d4
    5-Hydroxy dantrolene-d4 is the deuterium labeled 5-Hydroxy dantrolene.
    5-Hydroxy dantrolene-d<sub>4</sub>
  • HY-P11510S
    SCTTESCDFV-(Arg-13C6,15N4) TFA
    SCTTESCDFV-(Arg-13C6,15N4) TFA is the 13C- and 15N-labeled SCTTESCDFV.
    SCTTESCDFV-(Arg-<sup>13</sup>C<sub>6</sub>,<sup>15</sup>N<sub>4</sub>) TFA
  • HY-B0363S1
    Nimesulide-13C6
    Nimesulide-13C6 (R805-13C6) is 13C labeled Nimesulide. Nimesulide is a selective COX-2 inhibitor, with IC50s of 70 nM-70 μM in a time-dependent manner, but it shows no effect on COX-1 (IC50 >100 μM). Nimesulide has potent anti-inflammatory, analgesic and antipyretic properties.
    Nimesulide-<sup>13</sup>C<sub>6</sub>
  • HY-W741017S
    21-Desacetyl difluprednate-d6
    21-Desacetyl difluprednate-d6 is deuterium-labeled 21-Desacetyl Difluprednate (HY-W741017).
    21-Desacetyl difluprednate-d<sub>6</sub>
  • HY-W440454
    2-Phenylpyridine-d9
    2-Phenylpyridine-d9 is the deuterium labeled 2-Phenylpyridine-d9 (HY-W017077).
    2-Phenylpyridine-d<sub>9</sub>
  • HY-10268S2
    Betrixaban-13C6
    Betrixaban-13C6 (PRT054021-13C6) is 13C labeled Betrixaban. Betrixaban (PRT054021) is a highly potent, selective, and orally efficacious factor Xa (fXa) inhibitor with an IC50 of 1.5 nM. Betrixaban shows antithrombotic effect.
    Betrixaban-<sup>13</sup>C<sub>6</sub>
  • HY-W778183
    3,5,6-Trichloro-2-pyridinol-13C5
    3,5,6-Trichloro-2-pyridinol-13C5 (TCPy-13C5) is 13C labeled 3,5,6-Trichloro-2-pyridinol.
    3,5,6-Trichloro-2-pyridinol-<sup>13</sup>C<sub>5</sub>
  • HY-B0656S1
    Rabeprazole-13C,d3
    Rabeprazole-13C,d3 is a deuterated labeled Rabeprazole. Rabeprazole (LY307640) is a second-generation proton pump inhibitor (PPI) that irreversibly inactivates gastric H+/K+-ATPase. Rabeprazole induces apoptosis. Rabeprazole acts as an uridine nucleoside ribohydrolase (UNH) inhibitor with an IC50 of 0.3 μM. Rabeprazole can be used for the research of gastric ulcerations and gastroesophageal reflux.
    Rabeprazole-<sup>13</sup>C,d<sub>3</sub>
  • HY-W777599
    (±)-Naproxen-13C,d3-1
    (±)-Naproxen-13C,d3-1 ((Rac)-Naproxen-13C,d3-1) is 13C and deuterium labeled (±)-Naproxen.
    (±)-Naproxen-<sup>13</sup>C,d<sub>3</sub>-1
  • HY-100347S
    SRI-011381-d5
    SRI-011381-d5 is the deuterium labeled SRI-011381 (HY-100347). SRI-011381 is an orally active TGF-β signaling agonist, exhibits neuroprotective effects.
    SRI-011381-d<sub>5</sub>
  • HY-124303S
    4(Z),7(Z),10(Z),13(Z),16(Z)-Nonadecapentaenoic acid-d5
    4(Z),7(Z),10(Z),13(Z),16(Z)-Nonadecapentaenoic acid-d5 (FA 19:5-d5) is deuterium labeled 4(Z),7(Z),10(Z),13(Z),16(Z)-Nonadecapentaenoic acid.
    4(Z),7(Z),10(Z),13(Z),16(Z)-Nonadecapentaenoic acid-d<sub>5</sub>
  • HY-W020576S
    Rivastigmine metabolite-d6
    Rivastigmine metabolite-d6 (NAP 226-90-d6) is a deuterated form of Rivastigmine metabolite. Rivastigmine metabolite (NAP 226-90) is a metabolite produced by the hydrolysis of Rivastigmine (HY-17368). Rivastigmine metabolite serves as a surrogate marker to track the bioavailability, metabolic extent, and transdermal patch delivery rate of Rivastigmine.
    Rivastigmine metabolite-d<sub>6</sub>
  • HY-165662S
    Pranoprofen-13C-d3
    Pranoprofen-13C-d3 (Pyaopofe-13C-d3) is 13C and deuterium labeled Pranoprofen.
    Pranoprofen-<sup>13</sup>C-d<sub>3</sub>
  • HY-151993S
    2-Hydroxypropane-1,3-diyl distearate-d75
    2-Hydroxypropane-1,3-diyl distearate-d75 is deuterium labeled Glyceryl 1,3-distearate.
    2-Hydroxypropane-1,3-diyl distearate-d<sub>75</sub>
  • HY-W759845
    Aficamten-d3
    Aficamten-d3 (CK-274-d3) is deuterium labeled Aficamten. Aficamten (CK-274) is a potent cardiac myosin inhibitor with an IC50 of 1.4 μM. Aficamten can be used for the research of hypertrophic cardiomyopathy (HCM).
    Aficamten-d<sub>3</sub>
  • HY-132461S
    2-Hydroxy Desipramine-d3
    2-Hydroxy Desipramine-d3 is the deuterium labeled 2-Hydroxy Desipramine.
    2-Hydroxy Desipramine-d<sub>3</sub>
  • HY-100805S1
    D-Glutamic acid-13C5,15N
    D-Glutamic acid-13C5,15N ((R)-Glutamic acid-13C5,15N) is 13C and 15N labeled D-Glutamic acid. D-glutamic acid, an enantiomer of L- glutamic acid, is widely used in pharmaceuticals and foods.
    D-Glutamic acid-<sup>13</sup>C<sub>5</sub>,<sup>15</sup>N
  • HY-66006S1
    4-Acetaminophen sulfate-d4
    4-Acetaminophen sulfate-d4 is deuterated labeled 4-Acetaminophen sulfate.
    4-Acetaminophen sulfate-d<sub>4</sub>
  • HY-173090S
    VAVVR(pT)PPK(pS)PSSAK-(Lys-13C6,15N2) TFA
    VAVVR(pT)PPK(pS)PSSAK-(Lys-13C6,15N2) TFA is the 13C- and 15N-labeled VAVVR(pT)PPK(pS)PSSAK-(Lys) TFA.
    VAVVR(pT)PPK(pS)PSSAK-(Lys-<sup>13</sup>C<sub>6</sub>,<sup>15</sup>N<sub>2</sub>) TFA